Massimo D’Amato

2.3k total citations
36 papers, 1.7k citations indexed

About

Massimo D’Amato is a scholar working on Surgery, Cellular and Molecular Neuroscience and Gastroenterology. According to data from OpenAlex, Massimo D’Amato has authored 36 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Surgery, 13 papers in Cellular and Molecular Neuroscience and 9 papers in Gastroenterology. Recurrent topics in Massimo D’Amato's work include Neuropeptides and Animal Physiology (13 papers), Helicobacter pylori-related gastroenterology studies (9 papers) and Regulation of Appetite and Obesity (7 papers). Massimo D’Amato is often cited by papers focused on Neuropeptides and Animal Physiology (13 papers), Helicobacter pylori-related gastroenterology studies (9 papers) and Regulation of Appetite and Obesity (7 papers). Massimo D’Amato collaborates with scholars based in Italy, United Kingdom and Switzerland. Massimo D’Amato's co-authors include Christoph Beglinger, Jürgen Drewe, Lucio C. Rovati, Graham J. Dockray, David G. Thompson, John McLaughlin, Giampaolo Giacovelli, Daniel Matzinger, Lukas Degen and Maria Grazia Lucà and has published in prestigious journals such as Gastroenterology, PLoS ONE and NeuroImage.

In The Last Decade

Massimo D’Amato

36 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Massimo D’Amato Italy 21 520 492 482 363 354 36 1.7k
H. S. Füeßl United Kingdom 11 514 1.0× 303 0.6× 380 0.8× 376 1.0× 156 0.4× 53 1.3k
Peter Layer Germany 29 479 0.9× 1.1k 2.2× 470 1.0× 549 1.5× 404 1.1× 103 2.6k
Władysław Bielański Poland 32 681 1.3× 1.4k 2.8× 479 1.0× 388 1.1× 470 1.3× 102 2.8k
K. Sjölund Sweden 23 259 0.5× 783 1.6× 355 0.7× 202 0.6× 861 2.4× 48 2.2k
Amelia N. Pilichiewicz Australia 14 371 0.7× 425 0.9× 551 1.1× 287 0.8× 370 1.0× 27 1.3k
R.D.E. Rumsey United Kingdom 21 240 0.5× 352 0.7× 428 0.9× 297 0.8× 301 0.9× 34 1.2k
P. Lehnert Germany 14 558 1.1× 285 0.6× 395 0.8× 361 1.0× 136 0.4× 48 1.1k
D. L. Sarson United Kingdom 23 162 0.3× 523 1.1× 351 0.7× 354 1.0× 291 0.8× 42 1.7k
Tomohiko Taminato Japan 25 241 0.5× 757 1.5× 376 0.8× 147 0.4× 164 0.5× 109 2.1k
Koji Yakabi Japan 19 273 0.5× 338 0.7× 234 0.5× 201 0.6× 171 0.5× 68 991

Countries citing papers authored by Massimo D’Amato

Since Specialization
Citations

This map shows the geographic impact of Massimo D’Amato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo D’Amato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo D’Amato more than expected).

Fields of papers citing papers by Massimo D’Amato

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Massimo D’Amato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo D’Amato. The network helps show where Massimo D’Amato may publish in the future.

Co-authorship network of co-authors of Massimo D’Amato

This figure shows the co-authorship network connecting the top 25 collaborators of Massimo D’Amato. A scholar is included among the top collaborators of Massimo D’Amato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Massimo D’Amato. Massimo D’Amato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Navarro, Victor J., Steven H. Belle, Massimo D’Amato, et al.. (2019). Silymarin in non-cirrhotics with non-alcoholic steatohepatitis: A randomized, double-blind, placebo controlled trial. PLoS ONE. 14(9). e0221683–e0221683. 93 indexed citations
2.
Mercurio, Valentina, Giacomo Pucci, Giorgio Bosso, et al.. (2019). A nutraceutical combination reduces left ventricular mass in subjects with metabolic syndrome and left ventricular hypertrophy: A multicenter, randomized, double-blind, placebo-controlled trial. Clinical Nutrition. 39(5). 1379–1384. 18 indexed citations
3.
Malerba, Mario, Massimo D’Amato, Alessandro Radaeli, et al.. (2015). Efficacy of Andolast in Mild to Moderate Asthma: A Randomized, Controlled, Double-Blind Multicenter Study (The Andast Trial). Current Pharmaceutical Design. 21(26). 3835–3843. 14 indexed citations
4.
5.
Pais, Pilar & Massimo D’Amato. (2014). In Vivo Efficacy Study of Milk Thistle Extract (ETHIS-094™) in STAM™ Model of Nonalcoholic Steatohepatitis. Drugs in R&D. 14(4). 291–299. 16 indexed citations
6.
Little, Tanya J., Shane McKie, Richard B. Jones, et al.. (2014). Mapping glucose-mediated gut-to-brain signalling pathways in humans. NeuroImage. 96. 1–11. 37 indexed citations
7.
Bérenbaum, Francis, Joachim Grifka, Sara Cazzaniga, et al.. (2012). A randomised, double-blind, controlled trial comparing two intra-articular hyaluronic acid preparations differing by their molecular weight in symptomatic knee osteoarthritis. Annals of the Rheumatic Diseases. 71(9). 1454–1460. 108 indexed citations
8.
McKie, Shane, Lloyd J. Gregory, Simon Lal, et al.. (2010). Defining the Role of Cholecystokinin in the Lipid-Induced Human Brain Activation Matrix. Gastroenterology. 138(4). 1514–1524. 57 indexed citations
9.
Whorwell, Peter J., Fábio Pace, Massimo D’Amato, et al.. (2008). 1051 A Phase III, 6-Month, Double-Blind, Placebo-Controlled, Randomized Withdrawal Trial of the Selective CCK-1 Antagonist Dexloxiglumide in Constipation-Predominant IBS: the Darwin Study. Gastroenterology. 134(4). A–157. 6 indexed citations
10.
D’Amato, Massimo, et al.. (2006). CCK<sub>1</sub> Antagonists: Are They Ready for Clinical Use?. Digestive Diseases. 24(1-2). 70–82. 18 indexed citations
11.
Degen, Lukas, et al.. (2006). Effect of CCK-1 receptor blockade on ghrelin and PYY secretion in men. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 292(4). R1391–R1399. 69 indexed citations
12.
Varga, Gábor, András Bálint, Beáta Burghardt, & Massimo D’Amato. (2004). Involvement of endogenous CCK and CCK1 receptors in colonic motor function. British Journal of Pharmacology. 141(8). 1275–1284. 60 indexed citations
13.
Hall, Michael, Stefano Persiani, Ram P. Kapil, et al.. (2004). Interaction of dexloxiglumide, a cholecystokinin type‐1 receptor antagonist, with human cytochromes P450. Biopharmaceutics & Drug Disposition. 25(4). 163–176. 5 indexed citations
14.
Hebden, John M., Elaine Blackshaw, Massimo D’Amato, Alan C. Perkins, & Robert E. Spiller. (2002). Abnormalities of GI transit in bloated irritable bowel syndrome: effect of bran on transit and symptoms. The American Journal of Gastroenterology. 97(9). 2315–2320. 64 indexed citations
15.
McLaughlin, John, Maria Grazia Lucà, Malcolm N. Jones, et al.. (1999). Fatty acid chain length determines cholecystokinin secretion and effect on human gastric motility. Gastroenterology. 116(1). 46–53. 215 indexed citations
16.
Varga, Gábor, Krisztina Kisfalvi, Iva Pelosini, Massimo D’Amato, & Carmelo Scarpignato. (1998). Different actions of CCK on pancreatic and gastric growth in the rat: effect of CCKA receptor blockade. British Journal of Pharmacology. 124(3). 435–440. 19 indexed citations
17.
Clavé, Père, A. González, Antonio López‐Farré, et al.. (1998). Endogenous cholecystokinin enhances postprandial gastroesophageal reflux in humans through extrasphincteric receptors. Gastroenterology. 115(3). 597–604. 58 indexed citations
18.
D’Amato, Massimo & Lucio C. Rovati. (1997). Cholecystokinin-A receptor antagonists: therapies for gastrointestinal disorders. Expert Opinion on Investigational Drugs. 6(7). 819–836. 19 indexed citations
19.
Preziosi, P, Massimo D’Amato, Renata Del Carmine, et al.. (1992). The effects of 5-HT3 receptor antagonists on cisplatin-induced emesis in the pigeon. European Journal of Pharmacology. 221(2-3). 343–350. 19 indexed citations
20.
D’Amato, Massimo, et al.. (1988). Comparison of the effect of vasoactive intestinal polypeptide and non-adrenergic non-cholinergic neurone stimulation in the cat gastric fundus. European Journal of Pharmacology. 152(1-2). 71–82. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H. S. Füeßl Breakdown of academic impact, for papers by Peter Layer Breakdown of academic impact, for papers by Władysław Bielański Breakdown of academic impact, for papers by K. Sjölund Breakdown of academic impact, for papers by Amelia N. Pilichiewicz Breakdown of academic impact, for papers by R.D.E. Rumsey Breakdown of academic impact, for papers by P. Lehnert Breakdown of academic impact, for papers by D. L. Sarson Breakdown of academic impact, for papers by Tomohiko Taminato Breakdown of academic impact, for papers by Koji Yakabi
Rankless by CCL
2026